Genetic testing for Ebstein anomaly


Ebstein anomaly (EA) is a rare congenital tricuspid valve malformation, characterized by downward displacement of the septal leaflet and an atrialized right ventricle. About 80% of cases of EA are non-syndromic; in the other 20%, the anomaly is associated with a chromosomal or Mendelian syndrome. The prevalence of EA is estimated at about 1 per 20,000 live births, and accounts for less than 1% of all congenital heart defects. EA has autosomal dominant inheritance. Likely causative genes are: NKX2-5, MYH7 and TPM1. This Utility Gene Test was developed on the basis of an analysis of the literature and existing diagnostic protocols. It is useful for confirming diagnosis, as well as for differential diagnosis, potential risk assessment and access to clinical trials.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Nihoyannopoulos P, McKenna WJ, Smith G, Foale R. Echocardiographic assessment of the right ventricle in Ebstein’s anomaly: relation to clinical outcome. J Am Coll Cardiol 1986; 8(3): 627-35.

  • 2. Dima-Cozma C, Cojocaru DC, Chiriac S, Negru R, Mitu F. Ebstein’s anomaly. Rev Med Chir Soc Med Nat Iasi 2013; 117(3): 674-79.

  • 3. Digilio MC, Silvestri LM, Dallapiccola B, Marino B. Genetics of Ebstein Anomaly. In: Giamberti A, Chessa M. (eds) The Tricuspid Valve in Congenital Heart Disease. Springer, Milano 2014.

  • 4. Edwards WD. Embryology and pathologic features of Ebstein’s anomaly. Prog Pediatr Cardiol 1993; 2:5–15.

  • 5. Attenhofer Jost CH, Connolly HM, Dearani JA, Edwards WD, Danielson GK. Ebstein’s anomaly. Circulation 2007; 115(2): 277-85.

  • 6. Takemura N, Machida N, Nakagawa K, Amasaki H, Washizu M, Hirose H. Ebstein’s anomaly in a beagle dog. J Vet Med Sci 2003; 65(4): 531-33.

  • 7. Choi R, Lee SK, Moon HS, Park IC, Hyun C. Ebstein’s anomaly with an atrial septal defect in a jindo dog. The Canadian Veterinary Journal 2009; 50(4): 405-10.

  • 8. Yuan SM. Ebstein’s Anomaly: Genetics, Clinical Manifestations, and Management. Pediatr Neonatol 2017; 58(3): 211-215.

  • 9. Correa-Villaseñor A, Ferencz C, Neill CA, Wilson PD, Boughman JA. Ebstein’s malformation of the tricuspid valve: genetic and environmental factors. The Baltimore-Washington Infant Study Group. Teratology 1994; 50(2): 137-47.

  • 10. Andelfinger GU. Human Genetics of Ebstein Anomaly. In: Rickert-Sperling S., Kelly R., Driscoll D. (eds) Congenital Heart Diseases: The Broken Heart. Springer, Vienna 2016.

  • 11. Celermajer DS, Bull C, Till JA, Cullen S, Vassillikos VP, Sullivan ID, Allan L, Nihoyannopoulos P, Somerville J, Deanfield JE. Ebstein’s anomaly: Presentation and outcome from fetus to adult. J Am Coll Cardiol 1994; 23(1): 170–76.

  • 12. Flores Arizmendi A, Fernandez Pineda L, Quero Jimenez C, Maitre Azcarate MJ, Herráiz Sarachaga I, Urroz E, Pérez de León J, Luis Moya J, Quero Jiménez M. The clinical profile of Ebstein’s malformation as seen from the fetus to the adult in 52 patients. Cardiol Young 2004; 14(1): 55–63.

  • 13. Kelle AM, Bentley SJ, Rohena LO, Cabalka AK, Olson TM. Ebstein anomaly, left ventricular non-compaction, and early onset heart failure associated with a de novo α-tropomyosin gene mutation. Am J Med Genet A 2016; 170(8): 2186-90.

  • 14. Schott JJ, Benson DW, Basson CT, Pease W, Silberbach GM, Moak JP, Maron BJ, Seidman CE, Seidman JG. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 1998; 281(5373): 108 – 11.

  • 15. Elliott DA, Kirk EP, Yeoh T, Chandar S, McKenzie F, Taylor P, Grossfeld P, Fatkin D, Jones O, Hayes P, Feneley M, Harvey RP. Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: associations with atrial septal defect and hypoplastic left heart syndrome. J Am Coll Cardiol 2003; 41(11): 2072 – 76.

  • 16. McElhinney DB, Geiger E, Blinder J, Woodrow Benson D, & Goldmuntz E. NKX2.5 mutations in patients with congenital heart disease. J Am Coll Cardiol 2003; 42(9): 1650 – 55

  • 17. Postma AV, van Engelen K, van de Meerakker J, Rahman T, Probst S, Baars MJ, Bauer U, Pickardt T, Sperling SR, Berger F, Moorman AF, Mulder BJ, Thierfelder L, Keavney B, Goodship J, Klaassen S. Mutations in the sarcomere gene MYH7 in Ebstein anomaly. Circ Cardiovasc Genet 2011; 4(1):43-50.

  • 18. Chen H, Zhang W, Li D, Cordes TM, Mark Payne R, Shou W. Analysis of ventricular hypertrabeculation and noncompaction using genetically engineered mouse models. Pediatr Cardiol 2009; 30(5):626–34.

  • 19. de Lange FJ, Moorman AFM, Anderson RH, Männer J, Soufan AT, de Gier-de Vries C, Schneider MD, Webb S, van den Hoff MJ, Christoffels Vet al. Lineage and morphogenetic analysis of the cardiac valves. Circ Res 2004; 95(6):645–54.

  • 20. Meilhac SM, Esner M, Kerszberg M, Moss JE, Buckingham ME. Oriented clonal cell growth in the developing mouse myocardium underlies cardiac morphogenesis. J Cell Biol 2004; 164(1):97–09.

  • 21. Nijak A, Alaerts M, Kuiperi C, Corveleyn A, Suys B, Paelinck B, Saenen J, Van Craenenbroeck E, Van Laer L, Loeys B, Verstraeten A. Left ventricular non-compaction with Ebstein anomaly attributed to a TPM1 mutation. Eur J Med Genet 2018; 61(1):8-10.

  • 22. Chen B, Gagnon M, Shahangian S, Anderson NL, Howerton DA, Boone JD; Centers for Disease Control and Prevention (CDC). Good Laboratory Practices for Molecular Genetic Testing for Heritable Diseases and Conditions. MMWR Recomm Rep 2009; 58 (RR-6):1-37.


Journal + Issues